Corcept Therapeutics

CORTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.297 B

$113.76 +3.15%

Close of 21 Sept 2026

Revenue

$761.4M

#1679 by revenue

Earnings

$99.7M

#1313 by earnings

Shares outstanding

108,098,397

Latest filing cover page

P/E ratio

123.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#28BridgeBio PharmaBBIO$13.0B
#29Biomarin PharmaceuticalBMRN$12.4B
#30Corcept TherapeuticsCORT$12.3B
#31Madrigal PharmaceuticalsMDGL$12.1B
#32Elanco Animal HealthELAN$11.2B

What if Corcept Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$280,060.16

Per share 2,462× higher

Bitcoin $1.72T

$15,909.61

Per share 140× higher

Nvidia $5.48T

$50,693.24

Per share 446× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Corcept Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.